A Phase II Multicenter Study Of Lometrexol Sodium And Folic Acid In Subjects With Previously Treated Stage IIIB or IV Non-Small Cell Lung Cancer
Sponsor study identifier
Secondary identifiers
interventional
N/A
1 country
7
Study Start
February 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedRATIONALE: Lometrexol may stop or slow the growth of tumor cells by blocking the enzymes necessary for tumor cell growth. Folic acid may be effective in preventing or lessening the side effects of lometrexol. Combining lometrexol with folic acid may be an effective treatment for non-small cell lung cancer. PURPOSE: Phase II trial to study the effectiveness of combining lometrexol with folic acid in treating patients who have stage IIIB or stage IV non-small cell lung cancer that has been previously treated.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 2002
Date type not reportedThis date has not been verified as actual or estimated.
April 9, 2002
Actual (reported)August 6, 2003
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
UCSF Cancer Center and Cancer Research Institute
San Francisco, California, 94143-0128, United States
Cancer Centers of Florida (U.S. Oncology)
Orlando, Florida, 32806, United States
Louisiana State University School of Medicine
New Orleans, Louisiana, 70112-2822, United States
US Oncology - Albany Regional Cancer Center
Albany, New York, 12208, United States
U.S. Oncology Research Inc.
Houston, Texas, 77060, United States
Tyler Cancer Center
Tyler, Texas, 75702, United States
Cancer Care Northwest
David Tesarowski
Tularik
First Submitted
April 9, 2002
First Posted
August 6, 2003
Study Start
February 2002
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
January 6, 2014
Record last verified: 2002-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Spokane, Washington, 99202, United States